Sebastián Chiavenna

Sebastián Chiavenna began their career in 2002 as a PhD Fellow at the Virology Institute, INTA, where they worked on Bovine Viral Diarrhea Virus (BVDV). In 2008, they joined Ferrer as a Senior Corporate Marketing Manager and later became Head of Project Development, Medical Advisor for Biotechnology, and Scientific Marketing Manager. In 2020, they joined GlyCardial Diagnostics as a Board Director and Board Observer, and Caixa Capital Risc as a Senior Associate - Life Science Investment Funds. In 2022, they became a Board Director at Inbiomotion SL.

Sebastián Chiavenna's education history includes a Bachelor of Science (BSc) from the University of Buenos Aires, which they obtained between 1996 and 2002. Sebastián then went on to earn a Master of Business Administration (MBA) from EAE Business School between 2013 and 2015. In addition, they obtained a Doctor of Philosophy (PhD) from the University of Buenos Aires between 2002 and 2007. In 2012, they obtained a Clinical Trials Monitoring certification from Colegi Oficial de Metges de Barcelona. Lastly, in 2019 they obtained a Change and Marketing Leadership certification from Esade.